GA
DXCM icon

Geller Advisors’s DexCom DXCM Stock Holding History

Geller Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,773
Closed -$314K – 270
2024
Q2 		$314K Buy
2,773
+73
+3% +$9.23K 0.02% 198
2024
Q1 		$374K Sell
2,700
-60
-2% -$7.54K 0.03% 183
2023
Q4 		$342K Buy
2,760
+259
+10% +$26.5K 0.03% 179
2023
Q3 		$233K Sell
2,501
-20
-0.8% -$2.25K 0.03% 221
2023
Q2 		$324K Buy
+2,521
New +$305K 0.04% 174

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geller Advisors's DXCM Position: Q3 2024 in Review

Geller Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,773 shares — an estimated $314K sold.

Geller Advisors first reported a position in DXCM in Q2 2023 and held it in 5 quarters. The position peaked at $374K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Geller Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Geller Advisors sold 2,773 DexCom shares in Q3 2024, an estimated $314K.
  • Geller Advisors first reported a position in DexCom in Q2 2023 and held it in 5 quarters.
  • Geller Advisors's DexCom position peaked at $374K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Geller Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.